There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Opioid QuOTA Act
Opioid Quota Openness, Transparency, and Awareness Act of 2019

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.


Actions Overview (1)

Date
05/08/2019Introduced in Senate

All Actions (1)

Date
05/08/2019Read twice and referred to the Committee on the Judiciary.
Action By: Senate

Cosponsors (5)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Shaheen, Jeanne [D-NH]* 05/08/2019
Sen. Brown, Sherrod [D-OH]* 05/08/2019
Sen. Durbin, Richard J. [D-IL]* 05/08/2019
Sen. Hassan, Margaret Wood [D-NH]* 05/08/2019
Sen. Manchin, Joe, III [D-WV]* 05/08/2019

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Judiciary05/08/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (6)


Latest Summary (1)

There is one summary for S.1366. View summaries

Shown Here:
Introduced in Senate (05/08/2019)

Opioid Quota Openness, Transparency, and Awareness Act of 2019 or the Opioid QuOTA Act

This bill requires the Drug Enforcement Administration to make publicly available on its website certain information regarding opioid procurement quotas.

The term "opioid procurement quota" means the maximum quantity of opioid analgesics that a registered manufacturer may procure.